SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual congress of the Heart Failure Association (HFA) of ...
CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial ...
Diuretics like furosemide have no role in the treatment of chronic venous insufficiency, but unfortunately, I still see them used frequently. However, a person can have both heart failure and venous ...
SQ Innovation, developer of Lasix® ONYU, today announced two important regulatory milestones in its international expansion strategy: the receipt of a CE marking certificate for the Lasix ONYU device, ...
The pre-programmed device delivers 30mg of furosemide over the first hour followed by 12.5mg per hour for the subsequent 4 hours. The Food and Drug Administration (FDA) has approved Lasix ® ONYU ...
Diuretics like furosemide have no role in the treatment of chronic venous insufficiency, but unfortunately, I still see them used frequently. However, a person can have both heart failure and venous ...
Racing rule changes regarding the pre-race administration of furosemide (Salix, commonly called Lasix) appear unlikely following the results of a pair of studies that assessed the diuretic used to ...
Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X If you buy the party line, practically every horse in training in the U. S. needs Lasix to stop it from bleeding. A ...
Galvanized by tragedy and united in bad publicity, horse racing’s major racetracks have teamed up to collectively phase out race-day use of the medicine Lasix. Sounds great, right? No one is going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results